Nigerian Manufacturer Codix Bio Ramps Up Production of HIV and Malaria Test Kits

Codix Bio Ltd, a Nigerian manufacturing firm, is set to spearhead the local production of HIV and malaria test kits at its newly established plant outside Lagos, tackling the shortfall resulting from a dip in U.S. foreign aid. The plant's production not only serves Nigeria but aims to extend across the regional market.

The United States, renowned as the world's most significant humanitarian donor, has slashed its foreign aid budget, which predominantly operates via USAID. In 2024 alone, U.S. financial aid to Nigeria stood at $740 million, primarily aimed at combating malaria and HIV diffusion.

Amidst fears about the implications of these financial cuts, Nigeria's government plans fundraising efforts to support ongoing programs. General Manager Olanrewaju Balaja disclosed the company's capacity and future plans to Reuters, stating potential expansions across West and Sub-Saharan Africa.

(With inputs from agencies.)